Objective To examine the regulatory effects of a potential antifibrotic tetrapeptide called N-acetyl-seryl-aspartyl-lysyl-proline(Ac-SDKP)on the expression of epidermal growth factor(EGFR)and signal transducer and act...Objective To examine the regulatory effects of a potential antifibrotic tetrapeptide called N-acetyl-seryl-aspartyl-lysyl-proline(Ac-SDKP)on the expression of epidermal growth factor(EGFR)and signal transducer and activator of transeription 3(STAT3)in lung tissues with fibrosis induced by silicosis in rats.This study aims to explore the potential therapeutic benefits of Ac-SDKP in the prevention and treatment of fibrotic lung diseases associated with silicosis.展开更多
文摘Objective To examine the regulatory effects of a potential antifibrotic tetrapeptide called N-acetyl-seryl-aspartyl-lysyl-proline(Ac-SDKP)on the expression of epidermal growth factor(EGFR)and signal transducer and activator of transeription 3(STAT3)in lung tissues with fibrosis induced by silicosis in rats.This study aims to explore the potential therapeutic benefits of Ac-SDKP in the prevention and treatment of fibrotic lung diseases associated with silicosis.